Seqera Labs, a Barcelona, Spain-based data orchestration and workflow software provider for life sciences, announced that it raised €22 million in Series A funding.
The round was led by Addition, with follow-on funding from Talis Capital, Speedinvest, BoxOne Ventures, and Amino Collective.
The additional funding will help Seqera Labs bolster its team as well as expand its product portfolio to be able to cover the entire data analysis lifecycle.
Series A follows a period of strong growth, with a 400% year-over-year revenue increase and a tripling of employees over the last 12 months. Seqera Labs was also pivotal in the COVID-19 variant detection with its technology, used to discover and track Alpha, Delta, and Omicron variants of the virus.
Tower, the company’s flagship workflows and data analysis platform, has also managed to expand its footprint and achieve rapid adoption, being used by over 150 leading pharmaceutical and biotechnology companies, including AstraZeneca, Janssen Pharmaceuticals, Oxford Nanopore, and Invitae.
Evan Floden, Co-Founder and CEO at Seqera Labs, comments: “Partnering with Addition, alongside our existing investors, Speedinvest and Talis Capital, as well as Boxone and Amino, demonstrates their belief in our direction and our ability to execute. Our ambition is to develop a portfolio of innovative products that positively impact millions of patients worldwide by optimizing drug research and discovery costs. We are delighted to be able to count on their support in achieving this goal.”
With this latest investment, Seqera aims to move beyond scientific workflows to encompass tool development, data management, reporting, infrastructure deployment, and interactive computing.
Company: Seqera Labs S.L.
Round: Series A
Funding Month: October 2022
Lead Investors: Addition
Additional Investors: Talis Capital, Speedinvest, BoxOne Ventures, and Amino Collective
Company Website: https://seqera.io/
Software Category: Data Orchestration and Workflow Software
About the Company: Founded in 2018 as a spin-off from the Centre for Genomic Regulation (CRG), Seqera Labs is the leading provider of open-source workflow orchestration software needed for data pipeline processing, cloud infrastructure, and secure collaboration. The team created Nextflow in 2013, the popular open-source workflow and data orchestration software that has become an industry standard among cloud providers, sequencing companies, and genomics platforms. Nextflow is used by thousands of organizations worldwide, is downloaded more than 55,000 times monthly, and is among the most successful open-source software projects in life sciences. Following the initial success of Nextflow, Seqera Labs aims to accelerate discovery and therapeutic breakthroughs through foundational open science software. Seqera Labs is on a mission to simplify complex data analysis pipelines in the cloud.